Maria Bech
Director/Board Member en PAXMAN AB .
Fortuna: 30 512 $ al 31/03/2024
Perfil
Maria Bech is the founder of Bech Pharma Consulting AB.
She currently holds three positions as Chief Executive Officer at EpiEndo Pharmaceuticals ehf, Director at Neuronano AB, and Independent Director at Paxman AB.
Ms. Bech has previously worked as VP-Clinical Development & Regulatory Affairs at Karo Healthcare AB, Manager-Clinical Project at AstraZeneca AB, and Chief Scientific Officer at Smartfish AS.
She has also held positions as Director at EQL Pharma AB, Independent Director at Iconovo AB, and Chief Scientific Officer at Smartfish AB.
Ms. Bech graduated from the University of Lund.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PAXMAN AB
0.05% | 31/12/2022 | 8 700 ( 0.05% ) | 30 512 $ | 31/03/2024 |
Cargos activos de Maria Bech
| Empresas | Cargo | Inicio |
|---|---|---|
| PAXMAN AB | Director/Board Member | 20/12/2016 |
| Neuronano AB | Director/Board Member | 01/06/2013 |
Bech Pharma Consulting AB
 Bech Pharma Consulting AB BiotechnologyHealth Technology Bech Pharma Consulting AB is a Swedish company that engages in the research and development of pharmaceutical products. The private company was founded by Maria Bech. | Founder | - |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Chief Executive Officer | 24/02/2021 |
Antiguos cargos conocidos de Maria Bech.
| Empresas | Cargo | Fin |
|---|---|---|
Smartfish AS
 Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
| KARO PHARMA AB (PUBL) | General Counsel | 01/04/2014 |
| Carassius Consulting | Corporate Officer/Principal | - |
| ICONOVO AB | Director/Board Member | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formación de Maria Bech.
| University of Lund | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| KARO PHARMA AB (PUBL) | Health Technology |
| EQL PHARMA AB | Health Technology |
| ICONOVO AB | Health Technology |
| PAXMAN AB | Health Technology |
| Empresas privadas | 7 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Smartfish AS
Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway. | Retail Trade |
| Neuronano AB | |
Smartfish AB
 Smartfish AB Beverages: Non-AlcoholicConsumer Non-Durables Part of Smartfish AS, Smartfish AB is a Swedish company that focuses on medical nutrition for cancer patients. The private company is based in Solna, Sweden. The company believes that good nutritional status is crucial for successful treatment and optimal outcomes. Smartfish has a slim and flexible organizational structure and aims to grow through strategic relationships with leading R&D, production, and distribution partners. The company's medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients. | Consumer Non-Durables |
Bech Pharma Consulting AB
Bech Pharma Consulting AB BiotechnologyHealth Technology Bech Pharma Consulting AB is a Swedish company that engages in the research and development of pharmaceutical products. The private company was founded by Maria Bech. | Health Technology |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Health Technology |
| Carassius Consulting |
- Bolsa de valores
- Insiders
- Maria Bech
